Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 7Not yet recruiting 2Completed 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 9Neoplasms 7Multiple Myeloma 7Prostatic Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Lung Neoplasms 6Colorectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Recurrence 5Rectal Neoplasms 5Neoplasm Metastasis 5Pancreatic Neoplasms 4Melanoma 4Leukemia, Myeloid, Acute 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hodgkin Disease 4Glioblastoma 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Urogenital Neoplasms 2

Interventions

Paclitaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Peritoneal Neoplasms × 30 days × Clear all
NCT04034251 2026-05-05

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
12 enrolled 18 charts
GastrointestinalGynecologic

Adenocarcinoma, Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡